McKesson Corporation
MCK
株式のランク
#190
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
株価
$1,005.18
最終同期: 2026-10-16
時価総額
$117.19B
変化（1日）
0.83%
変化（1年）
27.89%
国
US
取引 McKesson Corporation (MCK)
カテゴリー
Healthcare
McKesson Corporation（MCK）の営業利益率
October 2026 時点の営業利益率 TTM: 1.62%
McKesson Corporation の最新の財務報告と株価によると、現在の営業利益率（TTM）は 1.62% です。2024 年末時点では 1.27% でした。
McKesson Corporation の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.62% | 32.79% |
| 2025 | 1.22% | -3.94% |
| 2024 | 1.27% | -21.12% |
| 2023 | 1.61% | 56.31% |
| 2022 | 1.03% | -29.93% |
| 2021 | 1.47% | 13.08% |
| 2020 | 1.30% | -9.72% |
| 2019 | 1.44% | 2.86% |
| 2018 | 1.40% | -17.16% |
| 2017 | 1.69% | -16.34% |
| 2016 | 2.02% | 2.54% |
| 2015 | 1.97% | 2.07% |
| 2014 | 1.93% | -2.53% |
| 2013 | 1.98% | 2.06% |
| 2012 | 1.94% | 3.74% |
| 2011 | 1.87% | 1.08% |
| 2010 | 1.85% | 14.91% |
| 2009 | 1.61% | 11.03% |
| 2008 | 1.45% | 5.07% |
| 2007 | 1.38% | 3.76% |
| 2006 | 1.33% | 6.40% |
| 2005 | 1.25% | -11.35% |
| 2004 | 1.41% | -13.50% |
| 2003 | 1.63% | 17.27% |
| 2002 | 1.39% | 504.35% |
| 2001 | 0.23% | -46.51% |
| 2000 | 0.43% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 0.00% | - |
US
|
|
| 1.03% | -99.36% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -94.31% |
AU
|
|
| 5.69% | -96.49% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。